Wolff Wiese Magana’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.75K Hold
23
– – ﹤0.01% 575
2026
Q1
$6.41K Hold
23
– – ﹤0.01% 549
2025
Q4
$6.97K Hold
23
– – ﹤0.01% 514
2025
Q3
$6.45K Hold
23
– – ﹤0.01% 545
2025
Q2
$5.55K Sell
23
-41
-64% -$9.69K ﹤0.01% 542
2025
Q1
$15.6K Hold
64
– – 0.01% 339
2024
Q4
$21K Hold
64
– – 0.01% 291
2024
Q3
$21.4K Buy
+64
New +$20.3K 0.01% 292

Other funds holding BIO

Wolff Wiese Magana's BIO Position: Q2 2026 in Review

Wolff Wiese Magana held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 23 shares worth $6.75K. The position accounts for ﹤0.01% of the portfolio, ranked #575.

Wolff Wiese Magana first reported a position in BIO in Q3 2024 and has held it in 8 quarters since. The position peaked at $21.4K in Q3 2024. 400 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Wolff Wiese Magana held 23 shares of Bio-Rad Laboratories Class A worth $6.75K as of Q2 2026.
  • Wolff Wiese Magana left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Wolff Wiese Magana's portfolio in Q2 2026, its #575 holding.
  • Wolff Wiese Magana first reported a position in Bio-Rad Laboratories Class A in Q3 2024 and has held it in 8 quarters since.
  • Wolff Wiese Magana's Bio-Rad Laboratories Class A position peaked at $21.4K in Q3 2024.
  • 400 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Wolff Wiese Magana's 13F filing for Q2 2026, filed 13 Jul 2026.